JP2005504725A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005504725A5 JP2005504725A5 JP2002577776A JP2002577776A JP2005504725A5 JP 2005504725 A5 JP2005504725 A5 JP 2005504725A5 JP 2002577776 A JP2002577776 A JP 2002577776A JP 2002577776 A JP2002577776 A JP 2002577776A JP 2005504725 A5 JP2005504725 A5 JP 2005504725A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- oxo
- cyano
- dihydro
- pyrimidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000001875 compounds Chemical class 0.000 claims 25
- -1 nitro, amino Chemical group 0.000 claims 25
- 125000000217 alkyl group Chemical group 0.000 claims 18
- 125000003710 aryl alkyl group Chemical group 0.000 claims 10
- 125000003118 aryl group Chemical group 0.000 claims 8
- 125000001072 heteroaryl group Chemical group 0.000 claims 8
- 239000008194 pharmaceutical composition Substances 0.000 claims 8
- 229910052739 hydrogen Inorganic materials 0.000 claims 7
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims 6
- 125000000753 cycloalkyl group Chemical group 0.000 claims 6
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims 6
- 201000010099 disease Diseases 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 4
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 4
- 125000005885 heterocycloalkylalkyl group Chemical group 0.000 claims 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 4
- 230000002062 proliferating effect Effects 0.000 claims 4
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Divinylene sulfide Natural products C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 claims 3
- 125000001188 haloalkyl group Chemical group 0.000 claims 3
- 125000000623 heterocyclic group Chemical group 0.000 claims 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 3
- 229940127084 other anti-cancer agent Drugs 0.000 claims 3
- KHMFTRWKTPEGES-UHFFFAOYSA-N 4-(3-aminophenyl)-5-cyano-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxylic acid Chemical compound OC(=O)N1C(=O)NC(C)=C(C#N)C1C1=CC=CC(N)=C1 KHMFTRWKTPEGES-UHFFFAOYSA-N 0.000 claims 2
- JLLYLQLDYORLBB-UHFFFAOYSA-N 5-bromo-n-methylthiophene-2-sulfonamide Chemical compound CNS(=O)(=O)C1=CC=C(Br)S1 JLLYLQLDYORLBB-UHFFFAOYSA-N 0.000 claims 2
- HCEKHTXHBUOTBD-UHFFFAOYSA-N 5-cyano-4-(3,5-dichlorophenyl)-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxylic acid Chemical compound OC(=O)N1C(=O)NC(C)=C(C#N)C1C1=CC(Cl)=CC(Cl)=C1 HCEKHTXHBUOTBD-UHFFFAOYSA-N 0.000 claims 2
- FQGZYCCIGLIJFM-UHFFFAOYSA-N 5-cyano-6-methyl-4-(3-nitrophenyl)-2-oxo-1,4-dihydropyrimidine-3-carboxylic acid Chemical compound OC(=O)N1C(=O)NC(C)=C(C#N)C1C1=CC=CC([N+]([O-])=O)=C1 FQGZYCCIGLIJFM-UHFFFAOYSA-N 0.000 claims 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical class C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims 2
- 125000003545 alkoxy group Chemical group 0.000 claims 2
- 125000004103 aminoalkyl group Chemical group 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 125000005843 halogen group Chemical group 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 2
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 229910052717 sulfur Inorganic materials 0.000 claims 2
- 229930192474 thiophene Natural products 0.000 claims 2
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 claims 1
- PZNXVVIBILFGNE-UHFFFAOYSA-N 3-butanoyl-4-(3,5-dichlorophenyl)-6-methyl-2-oxo-1,4-dihydropyrimidine-5-carbonitrile Chemical compound N#CC1=C(C)NC(=O)N(C(=O)CCC)C1C1=CC(Cl)=CC(Cl)=C1 PZNXVVIBILFGNE-UHFFFAOYSA-N 0.000 claims 1
- AFTFIIOLGIFECX-UHFFFAOYSA-N 3-butanoyl-6-methyl-4-(3-nitrophenyl)-2-oxo-1,4-dihydropyrimidine-5-carbonitrile Chemical compound N#CC1=C(C)NC(=O)N(C(=O)CCC)C1C1=CC=CC([N+]([O-])=O)=C1 AFTFIIOLGIFECX-UHFFFAOYSA-N 0.000 claims 1
- JXYPBVSRLZVOLQ-UHFFFAOYSA-N 4-(2-bromophenyl)-5-cyano-n-ethyl-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxamide Chemical compound N#CC1=C(C)NC(=O)N(C(=O)NCC)C1C1=CC=CC=C1Br JXYPBVSRLZVOLQ-UHFFFAOYSA-N 0.000 claims 1
- MCLSNWBAQVPPKJ-UHFFFAOYSA-N 4-(3,5-difluorophenyl)-6-methyl-2-oxo-3-(piperidine-1-carbonyl)-1,4-dihydropyrimidine-5-carbonitrile Chemical compound O=C1NC(C)=C(C#N)C(C=2C=C(F)C=C(F)C=2)N1C(=O)N1CCCCC1 MCLSNWBAQVPPKJ-UHFFFAOYSA-N 0.000 claims 1
- AEWMCVWRKFDIOS-UHFFFAOYSA-N 4-(3,5-difluorophenyl)-6-methyl-2-oxo-3-(pyrrolidine-1-carbonyl)-1,4-dihydropyrimidine-5-carbonitrile Chemical compound O=C1NC(C)=C(C#N)C(C=2C=C(F)C=C(F)C=2)N1C(=O)N1CCCC1 AEWMCVWRKFDIOS-UHFFFAOYSA-N 0.000 claims 1
- DKXWBKSACMJKRO-UHFFFAOYSA-N 4-(3-bromo-4-fluorophenyl)-5-cyano-n-cyclopropyl-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxamide Chemical compound O=C1NC(C)=C(C#N)C(C=2C=C(Br)C(F)=CC=2)N1C(=O)NC1CC1 DKXWBKSACMJKRO-UHFFFAOYSA-N 0.000 claims 1
- JRQFEIBAJAAVLL-UHFFFAOYSA-N 4-(3-bromo-4-fluorophenyl)-5-cyano-n-ethyl-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxamide Chemical compound N#CC1=C(C)NC(=O)N(C(=O)NCC)C1C1=CC=C(F)C(Br)=C1 JRQFEIBAJAAVLL-UHFFFAOYSA-N 0.000 claims 1
- DHSUFVYMURODJI-UHFFFAOYSA-N 4-(3-bromophenyl)-5-cyano-n-ethyl-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxamide Chemical compound N#CC1=C(C)NC(=O)N(C(=O)NCC)C1C1=CC=CC(Br)=C1 DHSUFVYMURODJI-UHFFFAOYSA-N 0.000 claims 1
- PWBCEYUDTAROOK-UHFFFAOYSA-N 4-(3-chlorophenyl)-5-cyano-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxylic acid Chemical compound OC(=O)N1C(=O)NC(C)=C(C#N)C1C1=CC=CC(Cl)=C1 PWBCEYUDTAROOK-UHFFFAOYSA-N 0.000 claims 1
- CMRMUBNTUGFTHU-UHFFFAOYSA-N 4-(4-bromothiophen-2-yl)-5-cyano-n-ethyl-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxamide Chemical compound N#CC1=C(C)NC(=O)N(C(=O)NCC)C1C1=CC(Br)=CS1 CMRMUBNTUGFTHU-UHFFFAOYSA-N 0.000 claims 1
- YNICEONECVLJGT-UHFFFAOYSA-N 4-(4-chlorophenyl)-5-cyano-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxylic acid Chemical compound OC(=O)N1C(=O)NC(C)=C(C#N)C1C1=CC=C(Cl)C=C1 YNICEONECVLJGT-UHFFFAOYSA-N 0.000 claims 1
- AEUTYMFRFGWCHX-UHFFFAOYSA-N 4-(5-bromo-2-fluorophenyl)-5-cyano-n-cyclopropyl-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxamide Chemical compound O=C1NC(C)=C(C#N)C(C=2C(=CC=C(Br)C=2)F)N1C(=O)NC1CC1 AEUTYMFRFGWCHX-UHFFFAOYSA-N 0.000 claims 1
- RATJEUWKBJCYFY-UHFFFAOYSA-N 4-(5-bromo-2-fluorophenyl)-5-cyano-n-ethyl-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxamide Chemical compound N#CC1=C(C)NC(=O)N(C(=O)NCC)C1C1=CC(Br)=CC=C1F RATJEUWKBJCYFY-UHFFFAOYSA-N 0.000 claims 1
- PVDQGWMCZISBTO-UHFFFAOYSA-N 4-[2,5-bis(trifluoromethyl)phenyl]-5-cyano-n-ethyl-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxamide Chemical compound N#CC1=C(C)NC(=O)N(C(=O)NCC)C1C1=CC(C(F)(F)F)=CC=C1C(F)(F)F PVDQGWMCZISBTO-UHFFFAOYSA-N 0.000 claims 1
- OBFMSYUDCLNFRX-UHFFFAOYSA-N 4-[3,5-bis(trifluoromethyl)phenyl]-5-cyano-n-ethyl-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxamide Chemical compound N#CC1=C(C)NC(=O)N(C(=O)NCC)C1C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 OBFMSYUDCLNFRX-UHFFFAOYSA-N 0.000 claims 1
- FRTMWQZXXLBLQG-UHFFFAOYSA-N 4-[5-(4-chlorophenyl)-1,3-oxazol-4-yl]-5-cyano-n-ethyl-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxamide Chemical compound N#CC1=C(C)NC(=O)N(C(=O)NCC)C1C1=C(C=2C=CC(Cl)=CC=2)OC=N1 FRTMWQZXXLBLQG-UHFFFAOYSA-N 0.000 claims 1
- RSBHCQXJBAPMLZ-UHFFFAOYSA-N 4-[5-(4-chlorophenyl)furan-2-yl]-5-cyano-n-ethyl-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxamide Chemical compound N#CC1=C(C)NC(=O)N(C(=O)NCC)C1C1=CC=C(C=2C=CC(Cl)=CC=2)O1 RSBHCQXJBAPMLZ-UHFFFAOYSA-N 0.000 claims 1
- OQKLBRLVAMZDBC-UHFFFAOYSA-N 4-butyl-5-cyano-n-ethyl-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxamide Chemical compound CCCCC1N(C(=O)NCC)C(=O)NC(C)=C1C#N OQKLBRLVAMZDBC-UHFFFAOYSA-N 0.000 claims 1
- RMNSXNVPRLZMFE-UHFFFAOYSA-N 5-cyano-4-(2,2-dimethylpropyl)-n-ethyl-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxamide Chemical compound CCNC(=O)N1C(CC(C)(C)C)C(C#N)=C(C)NC1=O RMNSXNVPRLZMFE-UHFFFAOYSA-N 0.000 claims 1
- LXYYXIHCVMZFSF-UHFFFAOYSA-N 5-cyano-4-(2,3-dichlorophenyl)-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxylic acid Chemical compound OC(=O)N1C(=O)NC(C)=C(C#N)C1C1=CC=CC(Cl)=C1Cl LXYYXIHCVMZFSF-UHFFFAOYSA-N 0.000 claims 1
- BLTSMYKQUSNBIC-UHFFFAOYSA-N 5-cyano-4-(2-fluorophenyl)-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxylic acid Chemical compound OC(=O)N1C(=O)NC(C)=C(C#N)C1C1=CC=CC=C1F BLTSMYKQUSNBIC-UHFFFAOYSA-N 0.000 claims 1
- UEIFYRTVKOSUDH-UHFFFAOYSA-N 5-cyano-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxylic acid Chemical compound OC(=O)N1C(=O)NC(C)=C(C#N)C1C1=CC=C(Cl)C(Cl)=C1 UEIFYRTVKOSUDH-UHFFFAOYSA-N 0.000 claims 1
- YIUUAAOXZNZMKM-UHFFFAOYSA-N 5-cyano-4-(3,5-dibromophenyl)-n-ethyl-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxamide Chemical compound N#CC1=C(C)NC(=O)N(C(=O)NCC)C1C1=CC(Br)=CC(Br)=C1 YIUUAAOXZNZMKM-UHFFFAOYSA-N 0.000 claims 1
- YKKZWYJATQCDGV-UHFFFAOYSA-N 5-cyano-4-(3,5-dichlorophenyl)-n-ethyl-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxamide Chemical compound N#CC1=C(C)NC(=O)N(C(=O)NCC)C1C1=CC(Cl)=CC(Cl)=C1 YKKZWYJATQCDGV-UHFFFAOYSA-N 0.000 claims 1
- MQAXUBWQUXPUBW-UHFFFAOYSA-N 5-cyano-4-(3,5-difluorophenyl)-n-ethyl-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxamide Chemical compound N#CC1=C(C)NC(=O)N(C(=O)NCC)C1C1=CC(F)=CC(F)=C1 MQAXUBWQUXPUBW-UHFFFAOYSA-N 0.000 claims 1
- MYPNLFFBDBCHPY-UHFFFAOYSA-N 5-cyano-4-(3-cyano-4-fluorophenyl)-n-ethyl-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxamide Chemical compound N#CC1=C(C)NC(=O)N(C(=O)NCC)C1C1=CC=C(F)C(C#N)=C1 MYPNLFFBDBCHPY-UHFFFAOYSA-N 0.000 claims 1
- GZXVHBYQEHFZSN-UHFFFAOYSA-N 5-cyano-4-(3-cyanophenyl)-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxylic acid Chemical compound OC(=O)N1C(=O)NC(C)=C(C#N)C1C1=CC=CC(C#N)=C1 GZXVHBYQEHFZSN-UHFFFAOYSA-N 0.000 claims 1
- NHJKIOBHUGBFIE-UHFFFAOYSA-N 5-cyano-4-(3-fluorophenyl)-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxylic acid Chemical compound OC(=O)N1C(=O)NC(C)=C(C#N)C1C1=CC=CC(F)=C1 NHJKIOBHUGBFIE-UHFFFAOYSA-N 0.000 claims 1
- KYDDACRVISPBLK-UHFFFAOYSA-N 5-cyano-4-(3-methoxyphenyl)-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxylic acid Chemical compound COC1=CC=CC(C2C(=C(C)NC(=O)N2C(O)=O)C#N)=C1 KYDDACRVISPBLK-UHFFFAOYSA-N 0.000 claims 1
- UMYROHUFRUUKRR-UHFFFAOYSA-N 5-cyano-4-(4-fluorophenyl)-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxylic acid Chemical compound OC(=O)N1C(=O)NC(C)=C(C#N)C1C1=CC=C(F)C=C1 UMYROHUFRUUKRR-UHFFFAOYSA-N 0.000 claims 1
- NFLSVVZDASZPJE-UHFFFAOYSA-N 5-cyano-4-(4-methoxyphenyl)-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxylic acid Chemical compound C1=CC(OC)=CC=C1C1C(C#N)=C(C)NC(=O)N1C(O)=O NFLSVVZDASZPJE-UHFFFAOYSA-N 0.000 claims 1
- LLKJLFRSFLDQNA-UHFFFAOYSA-N 5-cyano-4-[3-(dimethylamino)phenyl]-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxylic acid Chemical compound CN(C)C1=CC=CC(C2C(=C(C)NC(=O)N2C(O)=O)C#N)=C1 LLKJLFRSFLDQNA-UHFFFAOYSA-N 0.000 claims 1
- SLOKGPHGGRORDH-UHFFFAOYSA-N 5-cyano-4-cyclopropyl-n-ethyl-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxamide Chemical compound N#CC1=C(C)NC(=O)N(C(=O)NCC)C1C1CC1 SLOKGPHGGRORDH-UHFFFAOYSA-N 0.000 claims 1
- ZWAUKYAGJJLCRK-UHFFFAOYSA-N 5-cyano-6-methyl-2-oxo-4-[3-(trifluoromethyl)phenyl]-1,4-dihydropyrimidine-3-carboxylic acid Chemical compound OC(=O)N1C(=O)NC(C)=C(C#N)C1C1=CC=CC(C(F)(F)F)=C1 ZWAUKYAGJJLCRK-UHFFFAOYSA-N 0.000 claims 1
- XKQLETJWOVZNSU-UHFFFAOYSA-N 5-cyano-6-methyl-2-oxo-4-phenyl-1,4-dihydropyrimidine-3-carboxylic acid Chemical compound OC(=O)N1C(=O)NC(C)=C(C#N)C1C1=CC=CC=C1 XKQLETJWOVZNSU-UHFFFAOYSA-N 0.000 claims 1
- COUYKXWHWAJGHN-UHFFFAOYSA-N 5-cyano-6-methyl-4-(2-methylphenyl)-2-oxo-1,4-dihydropyrimidine-3-carboxylic acid Chemical compound OC(=O)N1C(=O)NC(C)=C(C#N)C1C1=CC=CC=C1C COUYKXWHWAJGHN-UHFFFAOYSA-N 0.000 claims 1
- SBWWFJQHPNSTTC-UHFFFAOYSA-N 5-cyano-6-methyl-4-(3-nitrophenyl)-2-oxo-n-(1,3-thiazol-2-yl)-1,4-dihydropyrimidine-3-carboxamide Chemical compound O=C1NC(C)=C(C#N)C(C=2C=C(C=CC=2)[N+]([O-])=O)N1C(=O)NC1=NC=CS1 SBWWFJQHPNSTTC-UHFFFAOYSA-N 0.000 claims 1
- STCVXVZFLMASAW-UHFFFAOYSA-N 5-cyano-6-methyl-4-(3-nitrophenyl)-2-oxo-n-phenyl-1,4-dihydropyrimidine-3-carboxamide Chemical compound O=C1NC(C)=C(C#N)C(C=2C=C(C=CC=2)[N+]([O-])=O)N1C(=O)NC1=CC=CC=C1 STCVXVZFLMASAW-UHFFFAOYSA-N 0.000 claims 1
- FMRRBEMQMNPONH-UHFFFAOYSA-N 5-cyano-6-methyl-4-(3-nitrophenyl)-2-oxo-n-propan-2-yl-1,4-dihydropyrimidine-3-carboxamide Chemical compound N#CC1=C(C)NC(=O)N(C(=O)NC(C)C)C1C1=CC=CC([N+]([O-])=O)=C1 FMRRBEMQMNPONH-UHFFFAOYSA-N 0.000 claims 1
- KQQKOCNBEAFTJC-UHFFFAOYSA-N 5-cyano-6-methyl-4-(3-nitrophenyl)-2-oxo-n-propyl-1,4-dihydropyrimidine-3-carboxamide Chemical compound N#CC1=C(C)NC(=O)N(C(=O)NCCC)C1C1=CC=CC([N+]([O-])=O)=C1 KQQKOCNBEAFTJC-UHFFFAOYSA-N 0.000 claims 1
- MLVAGHWKSZGUEJ-UHFFFAOYSA-N 5-cyano-6-methyl-4-(3-nitrophenyl)-2-sulfanylidene-1,4-dihydropyrimidine-3-carboxylic acid Chemical compound OC(=O)N1C(=S)NC(C)=C(C#N)C1C1=CC=CC([N+]([O-])=O)=C1 MLVAGHWKSZGUEJ-UHFFFAOYSA-N 0.000 claims 1
- UDSMGCAEOBWISC-UHFFFAOYSA-N 5-cyano-6-methyl-4-(4-methylphenyl)-2-oxo-1,4-dihydropyrimidine-3-carboxylic acid Chemical compound OC(=O)N1C(=O)NC(C)=C(C#N)C1C1=CC=C(C)C=C1 UDSMGCAEOBWISC-UHFFFAOYSA-N 0.000 claims 1
- ORDWTDXFLRPLMP-UHFFFAOYSA-N 5-cyano-n,6-dimethyl-4-(3-nitrophenyl)-2-oxo-1,4-dihydropyrimidine-3-carboxamide Chemical compound N#CC1=C(C)NC(=O)N(C(=O)NC)C1C1=CC=CC([N+]([O-])=O)=C1 ORDWTDXFLRPLMP-UHFFFAOYSA-N 0.000 claims 1
- ROCIXKZORCDMCB-UHFFFAOYSA-N 5-cyano-n-(2-hydroxyethyl)-6-methyl-2-oxo-4-[3-(trifluoromethyl)phenyl]-1,4-dihydropyrimidine-3-carboxamide Chemical compound OCCNC(=O)N1C(=O)NC(C)=C(C#N)C1C1=CC=CC(C(F)(F)F)=C1 ROCIXKZORCDMCB-UHFFFAOYSA-N 0.000 claims 1
- IJDUOHJRDXMGOX-UHFFFAOYSA-N 5-cyano-n-(cyclopropylmethyl)-6-methyl-4-(3-nitrophenyl)-2-oxo-1,4-dihydropyrimidine-3-carboxamide Chemical compound O=C1NC(C)=C(C#N)C(C=2C=C(C=CC=2)[N+]([O-])=O)N1C(=O)NCC1CC1 IJDUOHJRDXMGOX-UHFFFAOYSA-N 0.000 claims 1
- DEPMHXVASNNUKH-UHFFFAOYSA-N 5-cyano-n-[2-(dimethylamino)ethyl]-6-methyl-2-oxo-4-[3-(trifluoromethyl)phenyl]-1,4-dihydropyrimidine-3-carboxamide Chemical compound N#CC1=C(C)NC(=O)N(C(=O)NCCN(C)C)C1C1=CC=CC(C(F)(F)F)=C1 DEPMHXVASNNUKH-UHFFFAOYSA-N 0.000 claims 1
- RCRKDSUIFFTZNC-UHFFFAOYSA-N 5-cyano-n-cyclopropyl-6-methyl-4-(3-nitrophenyl)-2-oxo-1,4-dihydropyrimidine-3-carboxamide Chemical compound O=C1NC(C)=C(C#N)C(C=2C=C(C=CC=2)[N+]([O-])=O)N1C(=O)NC1CC1 RCRKDSUIFFTZNC-UHFFFAOYSA-N 0.000 claims 1
- FQABDKGNCLNCMS-UHFFFAOYSA-N 5-cyano-n-ethyl-4-(2-methoxyphenyl)-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxamide Chemical compound N#CC1=C(C)NC(=O)N(C(=O)NCC)C1C1=CC=CC=C1OC FQABDKGNCLNCMS-UHFFFAOYSA-N 0.000 claims 1
- WQNROFNRNZKNBL-UHFFFAOYSA-N 5-cyano-n-ethyl-4-(3-methoxyphenyl)-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxamide Chemical compound N#CC1=C(C)NC(=O)N(C(=O)NCC)C1C1=CC=CC(OC)=C1 WQNROFNRNZKNBL-UHFFFAOYSA-N 0.000 claims 1
- HRWXZJVNCCICBB-UHFFFAOYSA-N 5-cyano-n-ethyl-4-[2-fluoro-5-(trifluoromethyl)phenyl]-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxamide Chemical compound N#CC1=C(C)NC(=O)N(C(=O)NCC)C1C1=CC(C(F)(F)F)=CC=C1F HRWXZJVNCCICBB-UHFFFAOYSA-N 0.000 claims 1
- WFTWCMCSPFYGPU-UHFFFAOYSA-N 5-cyano-n-ethyl-4-[3-(2-hydroxyethylcarbamoyl)phenyl]-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxamide Chemical compound N#CC1=C(C)NC(=O)N(C(=O)NCC)C1C1=CC=CC(C(=O)NCCO)=C1 WFTWCMCSPFYGPU-UHFFFAOYSA-N 0.000 claims 1
- ZYXCOVUQJWLSTR-UHFFFAOYSA-N 5-cyano-n-ethyl-4-[3-(ethylcarbamoyl)phenyl]-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxamide Chemical compound N#CC1=C(C)NC(=O)N(C(=O)NCC)C1C1=CC=CC(C(=O)NCC)=C1 ZYXCOVUQJWLSTR-UHFFFAOYSA-N 0.000 claims 1
- UGLJVFOXFPTZSK-UHFFFAOYSA-N 5-cyano-n-ethyl-6-methyl-2-oxo-4-(2-phenylethyl)-1,4-dihydropyrimidine-3-carboxamide Chemical compound N#CC1=C(C)NC(=O)N(C(=O)NCC)C1CCC1=CC=CC=C1 UGLJVFOXFPTZSK-UHFFFAOYSA-N 0.000 claims 1
- LNVNTVAZWXWBII-UHFFFAOYSA-N 5-cyano-n-ethyl-6-methyl-2-oxo-4-(4-phenyl-1,3-thiazol-5-yl)-1,4-dihydropyrimidine-3-carboxamide Chemical compound N#CC1=C(C)NC(=O)N(C(=O)NCC)C1C1=C(C=2C=CC=CC=2)N=CS1 LNVNTVAZWXWBII-UHFFFAOYSA-N 0.000 claims 1
- RFZXFNCKDNSPDV-UHFFFAOYSA-N 5-cyano-n-ethyl-6-methyl-2-oxo-4-(4-phenylthiophen-2-yl)-1,4-dihydropyrimidine-3-carboxamide Chemical compound N#CC1=C(C)NC(=O)N(C(=O)NCC)C1C1=CC(C=2C=CC=CC=2)=CS1 RFZXFNCKDNSPDV-UHFFFAOYSA-N 0.000 claims 1
- YBQAVFIVJTWUIV-UHFFFAOYSA-N 5-cyano-n-ethyl-6-methyl-2-oxo-4-(5-phenyl-1,3-oxazol-4-yl)-1,4-dihydropyrimidine-3-carboxamide Chemical compound N#CC1=C(C)NC(=O)N(C(=O)NCC)C1C1=C(C=2C=CC=CC=2)OC=N1 YBQAVFIVJTWUIV-UHFFFAOYSA-N 0.000 claims 1
- GWAVDXVIWHRDRZ-UHFFFAOYSA-N 5-cyano-n-ethyl-6-methyl-2-oxo-4-(5-pyridin-3-yl-1,3-oxazol-4-yl)-1,4-dihydropyrimidine-3-carboxamide Chemical compound N#CC1=C(C)NC(=O)N(C(=O)NCC)C1C1=C(C=2C=NC=CC=2)OC=N1 GWAVDXVIWHRDRZ-UHFFFAOYSA-N 0.000 claims 1
- YSQPNIXXNPOZIM-UHFFFAOYSA-N 5-cyano-n-ethyl-6-methyl-2-oxo-4-(phenylmethoxymethyl)-1,4-dihydropyrimidine-3-carboxamide Chemical compound N#CC1=C(C)NC(=O)N(C(=O)NCC)C1COCC1=CC=CC=C1 YSQPNIXXNPOZIM-UHFFFAOYSA-N 0.000 claims 1
- WWRFQBYDQNYRFL-UHFFFAOYSA-N 5-cyano-n-ethyl-6-methyl-2-oxo-4-[2-(trifluoromethyl)phenyl]-1,4-dihydropyrimidine-3-carboxamide Chemical compound N#CC1=C(C)NC(=O)N(C(=O)NCC)C1C1=CC=CC=C1C(F)(F)F WWRFQBYDQNYRFL-UHFFFAOYSA-N 0.000 claims 1
- HFEGEABHASSMCZ-UHFFFAOYSA-N 5-cyano-n-ethyl-6-methyl-2-oxo-4-[3-(trifluoromethyl)phenyl]-1,4-dihydropyrimidine-3-carboxamide Chemical compound N#CC1=C(C)NC(=O)N(C(=O)NCC)C1C1=CC=CC(C(F)(F)F)=C1 HFEGEABHASSMCZ-UHFFFAOYSA-N 0.000 claims 1
- QCBFJXOYQMMLCV-UHFFFAOYSA-N 5-cyano-n-ethyl-6-methyl-2-oxo-4-[4-(trifluoromethyl)-1,3-thiazol-5-yl]-1,4-dihydropyrimidine-3-carboxamide Chemical compound N#CC1=C(C)NC(=O)N(C(=O)NCC)C1C1=C(C(F)(F)F)N=CS1 QCBFJXOYQMMLCV-UHFFFAOYSA-N 0.000 claims 1
- NQVCYNCCNKAVQD-UHFFFAOYSA-N 5-cyano-n-ethyl-6-methyl-2-oxo-4-[5-[4-(trifluoromethyl)phenyl]-1,3-oxazol-4-yl]-1,4-dihydropyrimidine-3-carboxamide Chemical compound N#CC1=C(C)NC(=O)N(C(=O)NCC)C1C1=C(C=2C=CC(=CC=2)C(F)(F)F)OC=N1 NQVCYNCCNKAVQD-UHFFFAOYSA-N 0.000 claims 1
- NIGRXNXQOOAUMG-UHFFFAOYSA-N 5-cyano-n-ethyl-6-methyl-2-oxo-4-phenyl-1,4-dihydropyrimidine-3-carboxamide Chemical compound N#CC1=C(C)NC(=O)N(C(=O)NCC)C1C1=CC=CC=C1 NIGRXNXQOOAUMG-UHFFFAOYSA-N 0.000 claims 1
- BMKGAOAZWYUDFG-UHFFFAOYSA-N 5-cyano-n-ethyl-6-methyl-4-(3-methylthiophen-2-yl)-2-oxo-1,4-dihydropyrimidine-3-carboxamide Chemical compound N#CC1=C(C)NC(=O)N(C(=O)NCC)C1C1=C(C)C=CS1 BMKGAOAZWYUDFG-UHFFFAOYSA-N 0.000 claims 1
- ICYJYSINWKTKJW-UHFFFAOYSA-N 5-cyano-n-ethyl-6-methyl-4-[5-(4-nitrophenyl)-1,3-oxazol-4-yl]-2-oxo-1,4-dihydropyrimidine-3-carboxamide Chemical compound N#CC1=C(C)NC(=O)N(C(=O)NCC)C1C1=C(C=2C=CC(=CC=2)[N+]([O-])=O)OC=N1 ICYJYSINWKTKJW-UHFFFAOYSA-N 0.000 claims 1
- RLRDKIRJKWBRFI-UHFFFAOYSA-N 5-cyano-n-ethyl-6-methyl-4-naphthalen-1-yl-2-oxo-1,4-dihydropyrimidine-3-carboxamide Chemical compound N#CC1=C(C)NC(=O)N(C(=O)NCC)C1C1=CC=CC2=CC=CC=C12 RLRDKIRJKWBRFI-UHFFFAOYSA-N 0.000 claims 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 claims 1
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 claims 1
- KJJOUZOHPOGILO-UHFFFAOYSA-N FC(F)(F)CNC(=O)N1C(=O)NC(C)=C(C#N)C1C1=CC=CC([N+]([O-])=O)=C1 Chemical compound FC(F)(F)CNC(=O)N1C(=O)NC(C)=C(C#N)C1C1=CC=CC([N+]([O-])=O)=C1 KJJOUZOHPOGILO-UHFFFAOYSA-N 0.000 claims 1
- FDRBASGYAMOZMD-UHFFFAOYSA-N OCCNC(=O)N1C(=O)NC(C)=C(C#N)C1C1=CC=CC([N+]([O-])=O)=C1 Chemical compound OCCNC(=O)N1C(=O)NC(C)=C(C#N)C1C1=CC=CC([N+]([O-])=O)=C1 FDRBASGYAMOZMD-UHFFFAOYSA-N 0.000 claims 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical class C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 claims 1
- 229920000388 Polyphosphate Polymers 0.000 claims 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims 1
- 125000002252 acyl group Chemical group 0.000 claims 1
- 125000003342 alkenyl group Chemical group 0.000 claims 1
- 125000003302 alkenyloxy group Chemical group 0.000 claims 1
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims 1
- 230000006907 apoptotic process Effects 0.000 claims 1
- 125000004104 aryloxy group Chemical group 0.000 claims 1
- ABBZJHFBQXYTLU-UHFFFAOYSA-N but-3-enamide Chemical compound NC(=O)CC=C ABBZJHFBQXYTLU-UHFFFAOYSA-N 0.000 claims 1
- 239000004202 carbamide Substances 0.000 claims 1
- 125000002837 carbocyclic group Chemical group 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 125000004093 cyano group Chemical group *C#N 0.000 claims 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 125000005745 ethoxymethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])* 0.000 claims 1
- SJCVAILDOHKIJV-UHFFFAOYSA-N ethyl 4-(2-bromo-1,3-thiazol-5-yl)-5-cyano-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxylate Chemical compound N#CC1=C(C)NC(=O)N(C(=O)OCC)C1C1=CN=C(Br)S1 SJCVAILDOHKIJV-UHFFFAOYSA-N 0.000 claims 1
- SKGHNFGNKDWRLQ-UHFFFAOYSA-N ethyl 4-(2-bromophenyl)-5-cyano-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxylate Chemical compound N#CC1=C(C)NC(=O)N(C(=O)OCC)C1C1=CC=CC=C1Br SKGHNFGNKDWRLQ-UHFFFAOYSA-N 0.000 claims 1
- MCHCHVMXTSKSAT-UHFFFAOYSA-N ethyl 4-(3-bromophenyl)-5-cyano-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxylate Chemical compound N#CC1=C(C)NC(=O)N(C(=O)OCC)C1C1=CC=CC(Br)=C1 MCHCHVMXTSKSAT-UHFFFAOYSA-N 0.000 claims 1
- HHRQSLDYEGEEJU-UHFFFAOYSA-N ethyl 4-(4-bromothiophen-2-yl)-5-cyano-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxylate Chemical compound N#CC1=C(C)NC(=O)N(C(=O)OCC)C1C1=CC(Br)=CS1 HHRQSLDYEGEEJU-UHFFFAOYSA-N 0.000 claims 1
- BZPXUHJKVGMJNN-UHFFFAOYSA-N ethyl 4-[2,5-bis(trifluoromethyl)phenyl]-5-cyano-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxylate Chemical compound N#CC1=C(C)NC(=O)N(C(=O)OCC)C1C1=CC(C(F)(F)F)=CC=C1C(F)(F)F BZPXUHJKVGMJNN-UHFFFAOYSA-N 0.000 claims 1
- VPNSURRZVZDBJW-UHFFFAOYSA-N ethyl 4-[3,5-bis(trifluoromethyl)phenyl]-5-cyano-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxylate Chemical compound N#CC1=C(C)NC(=O)N(C(=O)OCC)C1C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 VPNSURRZVZDBJW-UHFFFAOYSA-N 0.000 claims 1
- NFFSSDXNLKSJFB-UHFFFAOYSA-N ethyl 4-[5-(4-chlorophenyl)-1,3-oxazol-4-yl]-5-cyano-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxylate Chemical compound N#CC1=C(C)NC(=O)N(C(=O)OCC)C1C1=C(C=2C=CC(Cl)=CC=2)OC=N1 NFFSSDXNLKSJFB-UHFFFAOYSA-N 0.000 claims 1
- CTWGUFODIIVIIK-UHFFFAOYSA-N ethyl 4-butyl-5-cyano-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxylate Chemical compound CCCCC1N(C(=O)OCC)C(=O)NC(C)=C1C#N CTWGUFODIIVIIK-UHFFFAOYSA-N 0.000 claims 1
- CNSRYYQSMSKLOD-UHFFFAOYSA-N ethyl 5-(4-chlorophenyl)-2-[5-cyano-3-(ethylcarbamoyl)-6-methyl-2-oxo-1,4-dihydropyrimidin-4-yl]furan-3-carboxylate Chemical compound N#CC1=C(C)NC(=O)N(C(=O)NCC)C1C1=C(C(=O)OCC)C=C(C=2C=CC(Cl)=CC=2)O1 CNSRYYQSMSKLOD-UHFFFAOYSA-N 0.000 claims 1
- UGGAOYBWKAUPOG-UHFFFAOYSA-N ethyl 5-cyano-4-(2-methoxyphenyl)-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxylate Chemical compound N#CC1=C(C)NC(=O)N(C(=O)OCC)C1C1=CC=CC=C1OC UGGAOYBWKAUPOG-UHFFFAOYSA-N 0.000 claims 1
- WENLJWFHXIQNTI-UHFFFAOYSA-N ethyl 5-cyano-4-(3,5-difluorophenyl)-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxylate Chemical compound N#CC1=C(C)NC(=O)N(C(=O)OCC)C1C1=CC(F)=CC(F)=C1 WENLJWFHXIQNTI-UHFFFAOYSA-N 0.000 claims 1
- PSAQGVCSAGYBPL-UHFFFAOYSA-N ethyl 5-cyano-4-(3,5-dimethyl-1,2-oxazol-4-yl)-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxylate Chemical compound N#CC1=C(C)NC(=O)N(C(=O)OCC)C1C1=C(C)ON=C1C PSAQGVCSAGYBPL-UHFFFAOYSA-N 0.000 claims 1
- TWDGPNZUSOWQHE-UHFFFAOYSA-N ethyl 5-cyano-4-(3-cyano-4-fluorophenyl)-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxylate Chemical compound N#CC1=C(C)NC(=O)N(C(=O)OCC)C1C1=CC=C(F)C(C#N)=C1 TWDGPNZUSOWQHE-UHFFFAOYSA-N 0.000 claims 1
- ALKSCUQCAGPHFY-UHFFFAOYSA-N ethyl 5-cyano-4-(3-methoxycarbonylphenyl)-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxylate Chemical compound N#CC1=C(C)NC(=O)N(C(=O)OCC)C1C1=CC=CC(C(=O)OC)=C1 ALKSCUQCAGPHFY-UHFFFAOYSA-N 0.000 claims 1
- XYSJRHLYEBWRIW-UHFFFAOYSA-N ethyl 5-cyano-4-[2-fluoro-5-(trifluoromethyl)phenyl]-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxylate Chemical compound N#CC1=C(C)NC(=O)N(C(=O)OCC)C1C1=CC(C(F)(F)F)=CC=C1F XYSJRHLYEBWRIW-UHFFFAOYSA-N 0.000 claims 1
- XINZSROVULFHAM-UHFFFAOYSA-N ethyl 5-cyano-4-cyclohexyl-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxylate Chemical compound N#CC1=C(C)NC(=O)N(C(=O)OCC)C1C1CCCCC1 XINZSROVULFHAM-UHFFFAOYSA-N 0.000 claims 1
- STTVQBUAAOIOMN-UHFFFAOYSA-N ethyl 5-cyano-4-cyclopropyl-6-methyl-2-oxo-1,4-dihydropyrimidine-3-carboxylate Chemical compound N#CC1=C(C)NC(=O)N(C(=O)OCC)C1C1CC1 STTVQBUAAOIOMN-UHFFFAOYSA-N 0.000 claims 1
- BWDVNEAOHSSKOK-UHFFFAOYSA-N ethyl 5-cyano-6-methyl-2-oxo-4-(2-phenylethoxymethyl)-1,4-dihydropyrimidine-3-carboxylate Chemical compound N#CC1=C(C)NC(=O)N(C(=O)OCC)C1COCCC1=CC=CC=C1 BWDVNEAOHSSKOK-UHFFFAOYSA-N 0.000 claims 1
- XBZREKPGNQROIR-UHFFFAOYSA-N ethyl 5-cyano-6-methyl-2-oxo-4-(2-phenylmethoxyphenyl)-1,4-dihydropyrimidine-3-carboxylate Chemical compound N#CC1=C(C)NC(=O)N(C(=O)OCC)C1C1=CC=CC=C1OCC1=CC=CC=C1 XBZREKPGNQROIR-UHFFFAOYSA-N 0.000 claims 1
- XDKKYXVOXJDPDP-UHFFFAOYSA-N ethyl 5-cyano-6-methyl-2-oxo-4-(phenylmethoxymethyl)-1,4-dihydropyrimidine-3-carboxylate Chemical compound N#CC1=C(C)NC(=O)N(C(=O)OCC)C1COCC1=CC=CC=C1 XDKKYXVOXJDPDP-UHFFFAOYSA-N 0.000 claims 1
- XXMRDTQYGRUBEK-UHFFFAOYSA-N ethyl 5-cyano-6-methyl-2-oxo-4-[2-(trifluoromethyl)phenyl]-1,4-dihydropyrimidine-3-carboxylate Chemical compound N#CC1=C(C)NC(=O)N(C(=O)OCC)C1C1=CC=CC=C1C(F)(F)F XXMRDTQYGRUBEK-UHFFFAOYSA-N 0.000 claims 1
- WQNCFIXJTSCVHY-UHFFFAOYSA-N ethyl 5-cyano-6-methyl-2-oxo-4-[2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-4-yl]-1,4-dihydropyrimidine-3-carboxylate Chemical compound N#CC1=C(C)NC(=O)N(C(=O)OCC)C1C1=CSC(C=2C=CC(=CC=2)C(F)(F)F)=N1 WQNCFIXJTSCVHY-UHFFFAOYSA-N 0.000 claims 1
- ONSFMJZZZAKLOM-UHFFFAOYSA-N ethyl 5-cyano-6-methyl-2-oxo-4-[4-(trifluoromethyl)-1,3-thiazol-5-yl]-1,4-dihydropyrimidine-3-carboxylate Chemical compound N#CC1=C(C)NC(=O)N(C(=O)OCC)C1C1=C(C(F)(F)F)N=CS1 ONSFMJZZZAKLOM-UHFFFAOYSA-N 0.000 claims 1
- WBRFZXTXZHTEBO-UHFFFAOYSA-N ethyl 5-cyano-6-methyl-2-oxo-4-propan-2-yl-1,4-dihydropyrimidine-3-carboxylate Chemical compound CCOC(=O)N1C(C(C)C)C(C#N)=C(C)NC1=O WBRFZXTXZHTEBO-UHFFFAOYSA-N 0.000 claims 1
- YAZBGDORPCTELQ-UHFFFAOYSA-N ethyl 5-cyano-6-methyl-2-oxo-4-thiophen-2-yl-1,4-dihydropyrimidine-3-carboxylate Chemical compound N#CC1=C(C)NC(=O)N(C(=O)OCC)C1C1=CC=CS1 YAZBGDORPCTELQ-UHFFFAOYSA-N 0.000 claims 1
- SFDZPYUGUWGWPS-UHFFFAOYSA-N ethyl 5-cyano-6-methyl-2-oxo-4-thiophen-3-yl-1,4-dihydropyrimidine-3-carboxylate Chemical compound N#CC1=C(C)NC(=O)N(C(=O)OCC)C1C1=CSC=C1 SFDZPYUGUWGWPS-UHFFFAOYSA-N 0.000 claims 1
- QUMBBHCVESURSI-UHFFFAOYSA-N ethyl 5-cyano-6-methyl-4-(2-methyl-1,3-thiazol-4-yl)-2-oxo-1,4-dihydropyrimidine-3-carboxylate Chemical compound N#CC1=C(C)NC(=O)N(C(=O)OCC)C1C1=CSC(C)=N1 QUMBBHCVESURSI-UHFFFAOYSA-N 0.000 claims 1
- PTZOCRQXYQNXAP-UHFFFAOYSA-N ethyl 5-cyano-6-methyl-4-(3-methylthiophen-2-yl)-2-oxo-1,4-dihydropyrimidine-3-carboxylate Chemical compound N#CC1=C(C)NC(=O)N(C(=O)OCC)C1C1=C(C)C=CS1 PTZOCRQXYQNXAP-UHFFFAOYSA-N 0.000 claims 1
- RIFRSZYMHZAARS-UHFFFAOYSA-N ethyl 5-cyano-6-methyl-4-(5-methyl-1,2-oxazol-3-yl)-2-oxo-1,4-dihydropyrimidine-3-carboxylate Chemical compound N#CC1=C(C)NC(=O)N(C(=O)OCC)C1C1=NOC(C)=C1 RIFRSZYMHZAARS-UHFFFAOYSA-N 0.000 claims 1
- ADLUACBFYNDWLV-UHFFFAOYSA-N ethyl 5-cyano-6-methyl-4-naphthalen-1-yl-2-oxo-1,4-dihydropyrimidine-3-carboxylate Chemical compound N#CC1=C(C)NC(=O)N(C(=O)OCC)C1C1=CC=CC2=CC=CC=C12 ADLUACBFYNDWLV-UHFFFAOYSA-N 0.000 claims 1
- KBPYSCYVMMRXAT-UHFFFAOYSA-N ethyl 5-cyano-6-methyl-4-naphthalen-2-yl-2-oxo-1,4-dihydropyrimidine-3-carboxylate Chemical compound N#CC1=C(C)NC(=O)N(C(=O)OCC)C1C1=CC=C(C=CC=C2)C2=C1 KBPYSCYVMMRXAT-UHFFFAOYSA-N 0.000 claims 1
- 125000005842 heteroatom Chemical group 0.000 claims 1
- 239000012948 isocyanate Substances 0.000 claims 1
- 150000002513 isocyanates Chemical group 0.000 claims 1
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical class C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- LJXMOPGCJLSMOU-UHFFFAOYSA-N methyl 3-[5-cyano-3-(ethylcarbamoyl)-6-methyl-2-oxo-1,4-dihydropyrimidin-4-yl]benzoate Chemical compound N#CC1=C(C)NC(=O)N(C(=O)NCC)C1C1=CC=CC(C(=O)OC)=C1 LJXMOPGCJLSMOU-UHFFFAOYSA-N 0.000 claims 1
- UUEVFMOUBSLVJW-UHFFFAOYSA-N oxo-[[1-[2-[2-[2-[4-(oxoazaniumylmethylidene)pyridin-1-yl]ethoxy]ethoxy]ethyl]pyridin-4-ylidene]methyl]azanium;dibromide Chemical compound [Br-].[Br-].C1=CC(=C[NH+]=O)C=CN1CCOCCOCCN1C=CC(=C[NH+]=O)C=C1 UUEVFMOUBSLVJW-UHFFFAOYSA-N 0.000 claims 1
- 239000001205 polyphosphate Substances 0.000 claims 1
- 235000011176 polyphosphates Nutrition 0.000 claims 1
- 239000000651 prodrug Substances 0.000 claims 1
- 229940002612 prodrug Drugs 0.000 claims 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- VTVLLIZDFGILNN-UHFFFAOYSA-N s-ethyl 5-cyano-6-methyl-2-oxo-4-[3-(trifluoromethyl)phenyl]-1,4-dihydropyrimidine-3-carbothioate Chemical compound N#CC1=C(C)NC(=O)N(C(=O)SCC)C1C1=CC=CC(C(F)(F)F)=C1 VTVLLIZDFGILNN-UHFFFAOYSA-N 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- 229940124530 sulfonamide Drugs 0.000 claims 1
- 150000003456 sulfonamides Chemical class 0.000 claims 1
- QEJOKJVLMCOGBK-UHFFFAOYSA-N tert-butyl 2-[5-cyano-6-methyl-4-(3-nitrophenyl)-2-oxo-1,4-dihydropyrimidin-3-yl]acetate Chemical compound CC(C)(C)OC(=O)CN1C(=O)NC(C)=C(C#N)C1C1=CC=CC([N+]([O-])=O)=C1 QEJOKJVLMCOGBK-UHFFFAOYSA-N 0.000 claims 1
- 125000005309 thioalkoxy group Chemical group 0.000 claims 1
- 150000003577 thiophenes Chemical class 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27995601P | 2001-03-29 | 2001-03-29 | |
| PCT/US2002/009497 WO2002079149A2 (en) | 2001-03-29 | 2002-03-26 | Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005504725A JP2005504725A (ja) | 2005-02-17 |
| JP2005504725A5 true JP2005504725A5 (enExample) | 2005-12-22 |
Family
ID=23071059
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002577776A Withdrawn JP2005504725A (ja) | 2001-03-29 | 2002-03-26 | 新規なシアノ置換されたジヒドロピリミジン化合物および疾患を治療する用途 |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6809102B2 (enExample) |
| EP (1) | EP1373221A4 (enExample) |
| JP (1) | JP2005504725A (enExample) |
| KR (1) | KR20030086327A (enExample) |
| CN (1) | CN1507435A (enExample) |
| AR (1) | AR034585A1 (enExample) |
| BG (1) | BG108180A (enExample) |
| BR (1) | BR0208405A (enExample) |
| CA (1) | CA2442482A1 (enExample) |
| CZ (1) | CZ20032645A3 (enExample) |
| EE (1) | EE200300474A (enExample) |
| HR (1) | HRP20030875A2 (enExample) |
| HU (1) | HUP0400350A3 (enExample) |
| IL (1) | IL157441A0 (enExample) |
| IS (1) | IS6967A (enExample) |
| MX (1) | MXPA03008634A (enExample) |
| NO (1) | NO20034300L (enExample) |
| PE (1) | PE20021013A1 (enExample) |
| PL (1) | PL373759A1 (enExample) |
| RU (1) | RU2003130961A (enExample) |
| SK (1) | SK11062003A3 (enExample) |
| TW (1) | TWI228416B (enExample) |
| UY (1) | UY27232A1 (enExample) |
| WO (1) | WO2002079149A2 (enExample) |
| YU (1) | YU75803A (enExample) |
| ZA (2) | ZA200306648B (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6900214B2 (en) * | 2001-03-29 | 2005-05-31 | Bristol-Myers Squibb Company | Cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
| DK1847534T3 (da) * | 2001-12-11 | 2011-08-29 | Kyowa Hakko Kirin Co Ltd | Thiadiazolin-derivater til behandling af kræft |
| AR050920A1 (es) * | 2003-03-07 | 2006-12-06 | Astrazeneca Ab | Enantiomeros de heterociclos fusionados seleccionados y usos de los mismos |
| JP3947758B2 (ja) * | 2003-03-07 | 2007-07-25 | アストラゼネカ アクチボラグ | 新規縮合ヘテロサイクル及びその使用 |
| ATE537158T1 (de) | 2003-04-18 | 2011-12-15 | Kyowa Hakko Kirin Co Ltd | M-stage-kinesin-inhibitor |
| AU2004247551A1 (en) * | 2003-06-10 | 2004-12-23 | Fuji Photo Film Co., Ltd. | Thiadiazoline derivative |
| WO2005007124A2 (en) | 2003-07-23 | 2005-01-27 | Bristol-Myers Squibb Company | Substituted dihydropyrimidine inhibitors of calcium channel function |
| US7166603B2 (en) | 2003-07-23 | 2007-01-23 | Bristol-Myers Squibb Co. | Dihydropyrimidone inhibitors of calcium channel function |
| EP1675834A4 (en) * | 2003-10-16 | 2008-08-27 | Cytokinetics Inc | COMPOUNDS, COMPOSITIONS AND METHODS |
| BRPI0513513A (pt) * | 2004-07-22 | 2008-05-06 | Astrazeneca Ab | composto ou um sal farmaceuticamente aceitável do mesmo, processo para preparar o mesmo, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, e, métodos para produzir um efeito inibitório de eg5 e um efeito anticáncer em um animal de sangue quente, e para tratar carcinomas em um animal de sangue quente |
| US20060041128A1 (en) * | 2004-08-18 | 2006-02-23 | Astrazeneca Ab | Selected fused heterocyclics and uses thereof |
| BRPI0514390A (pt) * | 2004-08-18 | 2008-06-10 | Astrazeneca Ab | enanciÈmero de um composto ou um sal farmacêuticamente aceitável ou um éster hidrolisável in vivo do mesmo, uso do mesmo, métodos para o tratamento de cáncer, para produzir um efeito inibidor de eg5 em um animal de sangue quente e para tratar doenças, e, composição farmacêutica |
| WO2006060737A2 (en) * | 2004-12-03 | 2006-06-08 | Takeda San Diego, Inc. | Mitotic kinesin inhibitors |
| AU2006225637A1 (en) * | 2005-03-22 | 2006-09-28 | Fuji Photo Film Co., Ltd. | Therapeutic agent for hematopoietic tumor |
| JP5060285B2 (ja) * | 2005-03-22 | 2012-10-31 | 協和発酵キリン株式会社 | 固形腫瘍治療剤 |
| WO2006137490A1 (ja) * | 2005-06-24 | 2006-12-28 | Kyowa Hakko Kogyo Co., Ltd. | 再狭窄治療剤 |
| DE102006002065B4 (de) * | 2006-01-16 | 2007-11-29 | Infineon Technologies Austria Ag | Kompensationsbauelement mit reduziertem und einstellbarem Einschaltwiderstand |
| CN110464722B (zh) * | 2019-06-06 | 2023-05-23 | 暨南大学 | 一类小分子化合物或其药学上可接受的盐在制备抗肿瘤转移药物中的应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6211198B1 (en) | 1993-04-05 | 2001-04-03 | Synaptic Pharmaceutical Corporation | Dihydropyridines and new uses thereof |
| JP3200070B2 (ja) | 1994-11-16 | 2001-08-20 | シナプティック・ファーマスーティカル・コーポレーション | ジヒドロピリミジン類およびその使用 |
| WO1997017969A1 (en) | 1995-11-16 | 1997-05-22 | Synaptic Pharmaceutical Corporation | Dihydropyrimidines and uses thereof |
| WO1997042956A1 (en) | 1996-05-16 | 1997-11-20 | Synaptic Pharmaceutical Corporation | Didhydropyrimidines and uses thereof |
| US6172066B1 (en) | 1996-05-16 | 2001-01-09 | Synaptic Pharmaceutical Corporation | Dihydropyrimidines and uses thereof |
| US6080760A (en) | 1997-06-18 | 2000-06-27 | Merck & Co., Inc. | Alpha 1A adrenergic receptor antagonists |
| CA2294349A1 (en) | 1997-06-18 | 1998-12-23 | Michael A. Patane | Alpha 1aadrenergic receptor antagonists |
| WO1999025345A1 (en) | 1997-11-14 | 1999-05-27 | Merck & Co., Inc. | Alpha-1a adrenergic receptor antagonists |
| AU768834B2 (en) | 1998-04-01 | 2004-01-08 | Yale University | A method for selectively modulating the interactions between survivin and tubulin |
| US6300084B1 (en) | 1998-10-08 | 2001-10-09 | The Regents Of The University Of California | Anti-mitotic agent screening process |
| AUPQ171999A0 (en) | 1999-07-20 | 1999-08-12 | University Of Sydney, The | Neurotropic virus transport |
| DE19935303A1 (de) | 1999-07-28 | 2001-02-08 | Aventis Pharma Gmbh | Oligonukleotide zur Inhibierung der Expression von humanem eg5 |
| US6617115B1 (en) | 1999-10-27 | 2003-09-09 | Cytokinetics, Inc. | Methods of screening for modulators of cell proliferation |
| ES2263501T3 (es) | 1999-10-27 | 2006-12-16 | Cytokinetics, Inc. | Procedimiento y composiciones que utilizan quinazolinonas. |
| US6284480B1 (en) | 2000-04-03 | 2001-09-04 | Cytokinetics, Inc. | Antifungal assay |
| US6900214B2 (en) | 2001-03-29 | 2005-05-31 | Bristol-Myers Squibb Company | Cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
-
2002
- 2002-03-22 US US10/104,257 patent/US6809102B2/en not_active Expired - Lifetime
- 2002-03-25 PE PE2002000232A patent/PE20021013A1/es not_active Application Discontinuation
- 2002-03-25 TW TW091105771A patent/TWI228416B/zh not_active IP Right Cessation
- 2002-03-26 YU YU75803A patent/YU75803A/sh unknown
- 2002-03-26 EE EEP200300474A patent/EE200300474A/xx unknown
- 2002-03-26 IL IL15744102A patent/IL157441A0/xx unknown
- 2002-03-26 JP JP2002577776A patent/JP2005504725A/ja not_active Withdrawn
- 2002-03-26 SK SK1106-2003A patent/SK11062003A3/sk unknown
- 2002-03-26 WO PCT/US2002/009497 patent/WO2002079149A2/en not_active Ceased
- 2002-03-26 HR HR20030875A patent/HRP20030875A2/hr not_active Application Discontinuation
- 2002-03-26 CA CA002442482A patent/CA2442482A1/en not_active Abandoned
- 2002-03-26 CN CNA028074556A patent/CN1507435A/zh active Pending
- 2002-03-26 BR BR0208405-8A patent/BR0208405A/pt not_active IP Right Cessation
- 2002-03-26 PL PL02373759A patent/PL373759A1/xx not_active Application Discontinuation
- 2002-03-26 KR KR10-2003-7012604A patent/KR20030086327A/ko not_active Withdrawn
- 2002-03-26 CZ CZ20032645A patent/CZ20032645A3/cs unknown
- 2002-03-26 HU HU0400350A patent/HUP0400350A3/hu unknown
- 2002-03-26 RU RU2003130961/04A patent/RU2003130961A/ru not_active Application Discontinuation
- 2002-03-26 MX MXPA03008634A patent/MXPA03008634A/es unknown
- 2002-03-26 EP EP02728592A patent/EP1373221A4/en not_active Withdrawn
- 2002-03-27 AR ARP020101168A patent/AR034585A1/es unknown
- 2002-03-27 UY UY27232A patent/UY27232A1/es not_active Application Discontinuation
-
2003
- 2003-08-26 ZA ZA200306648A patent/ZA200306648B/en unknown
- 2003-09-17 BG BG108180A patent/BG108180A/xx unknown
- 2003-09-18 ZA ZA200307320A patent/ZA200307320B/en unknown
- 2003-09-24 IS IS6967A patent/IS6967A/is unknown
- 2003-09-26 NO NO20034300A patent/NO20034300L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2003130961A (ru) | Цианозамещенные дигидропиримидиновые соединения и их применение для лечения | |
| RU2326869C2 (ru) | Производные пиридазин-3(2h)-она в качестве ингибиторов фосфодиэстеразы 4 (pde4), способ их получения, фармацевтическая композиция и способ лечения | |
| RU2454405C2 (ru) | Производные 3-пиридинкарбоксамида и 2-пиразинкарбоксамида в качестве агентов, повышающих уровень лвп-холестерина | |
| CA2396824A1 (en) | Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme ikk-2 | |
| JP2007516173A5 (enExample) | ||
| JP2011528034A5 (enExample) | ||
| JP2008509982A5 (enExample) | ||
| JP2007519754A5 (enExample) | ||
| AR065814A1 (es) | Derivados de 5-fenilimidazolona,inhibidores de beta-secretasa,composiciones farmaceuticas que los contienen y usos para prevenir y/o tratar trastornos asociados a niveles beta-amiloides elevados. | |
| JP2005527625A5 (enExample) | ||
| CA2526866A1 (en) | Substituted 3-sulfur indoles for treating a disease mediated by crth2 | |
| RU2011109339A (ru) | Новые пиррольные ингибиторы s-нитрозоглутатионредуктазы в качестве терапевтических агентов | |
| JP2007519695A5 (enExample) | ||
| JP4915715B2 (ja) | フェニルピリダジン誘導体及びこれを含有する医薬 | |
| JP2008520665A5 (enExample) | ||
| RU2010120682A (ru) | Ингибиторы гистондезацетилазы | |
| JP2012526803A5 (enExample) | ||
| JP2013506637A5 (enExample) | ||
| JP2013505949A5 (enExample) | ||
| JP2009520686A5 (enExample) | ||
| RU2003115612A (ru) | Производные амидоалкилпиперидинов и амидоалкилпиперазинов, пригодные для лечения нарушений нервной системы | |
| JP2009520021A5 (enExample) | ||
| US6900214B2 (en) | Cyano-substituted dihydropyrimidine compounds and their use to treat diseases | |
| JP2020500192A5 (enExample) | ||
| CA2533747A1 (en) | Heterocyclic compounds useful as malonyl-coa decarboxylase inhibitors |